J&J raises Actelion takeover pressure with higher price: source

By Pamela Barbaglia and Anjuli Davies LONDON (Reuters) - U.S. healthcare company Johnson & Johnson has raised its offer for Actelion, a source told Reuters on Tuesday, stepping up pressure on the Swiss biotech firm to accept a takeover deal. J&J had increased its offer, which has not yet been made public, after nearly two months of informal talks which have so far not resulted in a deal, the source added. The main stumbling block is that Actelion wants J&J to become a major sharehold